跳至主要内容
临床试验/NCT02720705
NCT02720705已完成2 期

Transbucal Dexmedetomidine for the Prevention of Emergence Agitation After Sevoflurane Anaesthesia in Pre-school Children

Assiut University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2016年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
90
试验地点
1
主要终点
The agitation score up to 1hour postoperative.

研究概览

简要总结

The aim of this study is to evaluate the efficacy of transbucal dexmedetomidine given in preschool children undergoing tonsillectomy operations in the prevention sevoflurane agitation.

详细描述

Agitation during the emergence from general anesthesia is a great post-operative problem that often injures the patients themselves and requires the medical staff to restrain and calm them. The predisposing factors for emergence agitation include anesthesia, operation, and patient. Sevoflurane anesthesia results in higher incidence of emergence agitation than halothane, because of the rapid emergence, and its effects on central nervous system inducing convulsion and post-operative behavioral changes. The otorhinolaryngologic and ophthalmologic surgeries, post-operative pain, young age, pre-operative anxiety, no past surgical history, and adjustment disorder of patients are risk factors.

Dexmedetomidine (DEX), a selective α (2)-adrenoreceptor agonist. Intravenous DEX used after induction of anesthesia reduced sevoflurane-associated EA and postoperative pain in pediatric ambulatory surgery.

The investigators designed this study to prove the efficacy of oral dexmedetomidine a selective α (2)-adrenoreceptor agonist, on emergence agitation (EA), recovery profiles, and parents' satisfaction after sevoflurane anesthesia in tonsillectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
2 Years 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • ASA physical status I-II patients
  • aged 2-6 years
  • patient scheduled for elective tonsillectomy due to recurrent
  • chronic tonsillitis

排除标准

  • patients with known hypersensitivity to medication drugs
  • coagulation disorders
  • thrombocytopenia
  • significant cardiac
  • pulmonary
  • hepatic disease

研究组 & 干预措施

DEX I

Active Comparator

active comparator receive 0.5µg/kg dexmedetomidine orally half an hour before operation

干预措施: Dexmedetomidine (Drug)

Saline Control

Placebo Comparator

2ml oral 0.9%saline half an hour before operation

干预措施: saline (Drug)

DEX II

Active Comparator

active comparator receive,1µg/kg dexmedetomidine orally half an hour before operation

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

The agitation score up to 1hour postoperative.

时间窗: first postoperative hour

Agitation intensity will be assessed postoperatively by using agitation score 0= child is asleep. awake/calm =1. irritable/ consolable cry =2. inconsolable cry =3.the child is agitating and thrashing and restlessness Emergence delirium ≥ 3 agitation score will be performed in the following time points; at 5 min postoperative,10 min, 15, 30, 45, 60 min.

次要结局

  • Pain score assessed using the objective pain scale.(up to 1hour postoperative hour)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hala Saad Abdel-Ghaffar

MD

Assiut University

研究点 (1)

Loading locations...

相似试验

Transbucal Dexmedetomidine for Prevention of... | 临床试验